# OXCARBAZEPINE
> **ANDA209652** · Abbreviated New Drug Application (Generic) · Sponsor: BIONPHARMA · Approved 2022-11-04
## Drug
- **FDA Application Number:** ANDA209652
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXCARBAZEPINE
- **Generic name:** OXCARBAZEPINE
- **Active ingredients:** OXCARBAZEPINE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BIONPHARMA
- **Manufacturer:** Bionpharma Inc.
- **First approval:** 2022-11-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209652)
---
*AI Analytics · CC0 1.0*